“…In the last few years, a lot of more active and selective quinoline derivatives have been synthesized and biologically evaluated by modifying lead compounds ( Table 1 ). The most representative modifications are: (1) at position C-7 of quinoline ring system, generally with the introduction of appropriate substituents to improve solubility, (2) at the linker portion [ 34 ], that has been modified by different cyclic/acyclic 5-atoms-analogues with similar electronic features: pyridazinone-3-carboxyamide 3 [ 35 ], 3-oxo-3,4-dihydroquinoxaline 4 [ 36 ], 1H-imidazole-4-carboxamide or (E)-3-hydrosulfonylacrylamide 5 , 6 [ 37 ], 1,2,3-triazole-4-carboxamide 7 , 8 [ 38 , 39 ], 2-imidazolone-4-carboxamide 9 [ 40 ], acylhydrazone moiety 10 [ 41 ], pyridine/pyrimidine-2-carboxyamide 11 [ 42 ], 2-phenylquinoline-4-carboxamide 12 [ 33 ], 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety 13 [ 43 ], acyclic semicarbazones 14 [ 44 , 45 ], acylthiourea moiety [ 46 ], l,2,4-triazine-3,5-dione 15 [ 47 ], 1,8-naphthyridin-2-one 16 [ 48 ], 2-oxo-1,2-dihydropiridine-3-carboxamide 17 [ 49 ], 4-oxo-1,4-dihydroquinoline-3-carboxamide 18 [ 50 ], 5-(aminomethylene)pyrimidine-2,4,6-trione moiety 19 [ 51 ], 4-oxo-3,4-dihydrophthalazine-1-carboxamide 20 [ 52 ], pyrazolone 21 [ 53 ], and (thio)semicarbazone 22 [ 54 ].…”